PMS2 and neoplasm: MMRd is characterized by loss of nuclear immunostaining for at least one of the four MMR proteins that are routinely examined: MSH2, MSH6, MLH1, and PMS2 and results in microsatellite instability (MSI), a condition of mutation accumulation and elevated neoantigen production which enhances tumor immunogenicity and sensitivity to immune checkpoint inhibitors [3].